Replies to post #487 on Aethlon Medical Inc (AEMD)

[My 2 Cents]

Hey GWMAN - you should include the slides from the redchip conference in that post.

I'm going to start using it as some of the 'included DD' when I post about AEMD on other boards.

[GWMAN]

2009 Calendar, Coverage, Slides, etc.

==> The Robins Group Coverage (Dec. 3, 2008)

Note: Earnings Estimate for Calendar 2009 is 0.14

http://www.therobinsgroup.biz/files/12_03_08_AEMD_IC.pdf

==> Latest Letter to Shareholders (Feb. 24, 2009)

http://phx.corporate-ir.net/phoenix.zhtml?c=95588&p=irol-newsArticle&ID=1259383&highlight=

==> Slide Presentation from RedChip Conference (Mar. 24, 2009)

http://www.redchip.com/visibility/conferencePages/SanFran2009/PowerPointPresentations/AEMD/Aethlon_FINAL_RedChip032409.ppt#259,1,Aethlon

==> Latest CEO Webcast (Mar. 5, 2009)

http://www.ceocast.com/(1t5vjl331gce04nvkcnow433)/company.aspx?id=1049

==> Current Chart TA

http://www.stockta.com/cgi-bin/analysis.pl?symb=AEMD&num1=13&cobrand=&mode=stock

==> Updated 2009 Calendar

**Note that I will be bolding the milestones that have been acheived as I update this periodically.

March:

1. Results from HIV study (DONE)
http://phx.corporate-ir.net/phoenix.zhtml?c=95588&p=irol-newsArticle&ID=1265082&highlight=

2. Results from 30-day HCV study (Semi-Done)
http://phx.corporate-ir.net/phoenix.zhtml?c=95588&p=irol-newsArticle&ID=1269792&highlight=

April:
1. Notification on potential award from Bill and Melinda Gates Foundation

And regarding this potential grant, lets not forget the Nov 2007 announcement:

American India Foundation To Honor Aethlon Medical CEO
SAN DIEGO--(BUSINESS WIRE)--Nov. 7, 2007--Aethlon Medical, Inc. (OTCBB:AEMD), a pioneer in developing medical devices to treat infectious disease, disclosed today that its Chairman and CEO, James A. Joyce, will be presented the "Spirit of India" award at the America India Foundation (AIF) annual gala on December 1, 2007. The event, sponsored by the Bill & Melinda Gates Foundation, honors American business leaders who have demonstrated a commitment to accelerating social and economic change in India.


May/June:
1. Notification on potential 5-year contract award from BARDA/fed gov

2. Release of Annual Report

Unknown Month:
1. Announcment of agreement to test/treat Dengue Fever in India
2. Announcement on private placement or strategic partner
3. Announcment on the planned contract production partner referenced in the investment firm write-up (Done)
http://phx.corporate-ir.net/phoenix.zhtml?c=95588&p=irol-newsArticle&ID=1262531&highlight=
4. Completion/Establishment of production protocols and initial production of units for sale
5. Starting of clinical trials in U.S.
6. Announcment of trial partner in Europe